Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Grass Pollen Allergy - Overview
Grass Pollen Allergy - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Grass Pollen Allergy - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Grass Pollen Allergy - Companies Involved in Therapeutics Development
ALK-Abello AS
Allergy Therapeutics Plc
ASIT Biotech SA
DC4U BV
HAL Allergy BV
Regeneron Pharmaceuticals Inc
Roxall Medizin GmbH
Worg Pharmaceuticals Hangzhou Co Ltd
Grass Pollen Allergy - Drug Profiles
Allergen for Grass Pollen Allergy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Allergen for Pollen Grass Allergy Induced Allergic Rhinitis and Rhinoconjunctivitis - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
dupilumab - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
gp-ASIT - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Pollinex Quattro Grass - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
standardized grass pollen [timothy (Phleum pratense)] allergen extract - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Grass Pollen Allergy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccine for Grass Pollen Allergy and House Dust Mite Allergy - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
WP-1048 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Grass Pollen Allergy - Dormant Projects
Grass Pollen Allergy - Discontinued Products
Grass Pollen Allergy - Product Development Milestones
Featured News & Press Releases
May 06, 2021: Allergy Therapeutics: Completion of treatment phase in G309 study
Aug 26, 2020: Chronic hepatitis B: vaccine against grass pollen allergy as potential treatment
Nov 26, 2019: Allergy Therapeutics announces update to Grass MATA MPL phase III clinical programme
Jun 27, 2019: Allergy Therapeutics: Successful litigation settlement relating to PQ Grass Phase II Trial
Apr 25, 2019: Allergy Therapeutics provides regulatory and trading update
Jun 25, 2018: Allergy Therapeutics announces publication of data demonstrating long-lasting efficacy of Pollinex Quattro Grass vaccine in Immunotherapy
May 21, 2018: Allergy Therapeutics announces positive top-line results from its Grass MATA MPL Phase II dose ranging study
Feb 05, 2018: Landmark clinical study with grass pollen vaccine BM32 published
Jan 26, 2017: Biomay AG Reports Positive Results From A Second Phase IIb Trial With The Innovative 3rd Generation Grass Pollen Allergy Vaccine BM32
Sep 08, 2016: Grass pollen allergy vaccine also effective against hepatitis B
Jun 27, 2016: Allergy Therapeutics announces findings from mEEC dose range finding study G204
Jun 13, 2016: New Data From GAP Landmark Trial Confirm GRAZAX Prevents Asthma Symptoms in Children
Mar 04, 2016: Inflamax Research Announces the Successful Completion of Enrollment for the First Multi-center, Mobile Environmental Exposure Chamber (mEEC) Study
Feb 18, 2016: Allergy Therapeutics Announces Patient enrolment completed in US Phase IIb study of GrassMATAMPL
Jan 28, 2016: Biomay initiates new phase II clinical trial with grass pollen allergy vaccine BM32
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Grass Pollen Allergy, 2021
Number of Products under Development by Companies, 2021
Number of Products by Stage and Targets, 2021
Number of Products by Stage and Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Molecule Types, 2021
Number of Products by Stage and Molecule Types, 2021

List of Tables

List of Tables
Number of Products under Development for Grass Pollen Allergy, 2021
Number of Products under Development by Companies, 2021
Products under Development by Companies, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Grass Pollen Allergy - Pipeline by ALK-Abello AS, 2021
Grass Pollen Allergy - Pipeline by Allergy Therapeutics Plc, 2021
Grass Pollen Allergy - Pipeline by ASIT Biotech SA, 2021
Grass Pollen Allergy - Pipeline by DC4U BV, 2021
Grass Pollen Allergy - Pipeline by HAL Allergy BV, 2021
Grass Pollen Allergy - Pipeline by Regeneron Pharmaceuticals Inc, 2021
Grass Pollen Allergy - Pipeline by Roxall Medizin GmbH, 2021
Grass Pollen Allergy - Pipeline by Worg Pharmaceuticals Hangzhou Co Ltd, 2021
Grass Pollen Allergy - Dormant Projects, 2021
Grass Pollen Allergy - Discontinued Products, 2021